M46.96
Unspecified inflammatory spondylopathy, lumbar region
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified inflammatory spondylopathy of the lumbar region is a condition characterized by inflammation affecting the vertebrae in the lower back. This condition involves the spine's bones and joints, leading to pain and potential mobility issues. As the term 'unspecified' suggests, the exact cause or specific form of the inflammation has not been determined, making diagnosis and treatment more challenging. Patients experiencing symptoms in the lumbar area should seek medical evaluation for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Autoimmune reactions where the body's immune system mistakenly attacks spinal tissues Chronic inflammatory diseases such as ankylosing spondylitis or other spondyloarthropathies Infections affecting the spine, including bacterial or viral origins Degenerative changes coupled with inflammation Genetic predisposition increasing susceptibility to inflammatory spinal conditions
Key Symptoms: Persistent lower back pain that may worsen with rest or activity Stiffness in the lumbar region, especially after periods of inactivity Reduced flexibility or mobility in the lower back Muscle spasms or tenderness in the affected area Potential radiating pain into the hips or legs Limited range of motion in the lumbar spine
Diagnostic & Treatment
Diagnosis Path: Diagnosing unspecified inflammatory spondylopathy involves a combination of clinical assessment and diagnostic tests. Healthcare providers typically perform a physical examination focused on back mobility and tenderness. Imaging studies such as X-rays, MRI, or CT scans are essential to visualize inflammation or structural changes in the vertebrae. Laboratory tests may include blood work to check for markers of inflammation or infection and to rule out other conditions. Often, a diagnosis is made after excluding other specific causes of back pain.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to control pain and inflammation Physical therapy exercises tailored to strengthen the back muscles and improve flexibility Regular activity and posture management to reduce strain on the lumbar spine In severe cases, corticosteroids may be prescribed to decrease inflammation Biologic agents or disease-modifying anti-rheumatic drugs (DMARDs) in cases linked to autoimmune conditions Surgical intervention may be considered if structural damage causes significant impairment or neurological symptoms
Clinical Advice & FAQs
Billing Guidance
Is M46.96 a billable ICD-10 code?
Yes, M46.96 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M46.96?
Clinical documentation must specify the nature of Unspecified inflammatory spondylopathy, lumbar region and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
